Prelude Capital Management, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History
Prelude Capital Management, LLC
- $1.57 Billion
- Q3 2024
A detailed history of Prelude Capital Management, LLC transactions in Corbus Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 11,500 shares of CRBP stock, worth $129,260. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,500Holding current value
$129,260% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CRBP
# of Institutions
4Shares Held
38.7KCall Options Held
0Put Options Held
0-
Kingsbury Capital Investment Advisors LLC Evanston, IL33.7KShares$378,7880.01% of portfolio
-
Exane Derivatives2.65KShares$29,7860.0% of portfolio
-
American Portfolios Advisors Holbrook, NY2.31KShares$25,9860.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About Corbus Pharmaceuticals Holdings, Inc.
- Ticker CRBP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 125,268,000
- Market Cap $1.41B
- Description
- Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...